title: Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
abstract: BACKGROUND
  The progranulin gene (GRN) is mutated in 5-10% of patients with frontotemporal lobar degeneration (FTLD) and in about 20% of patients with familial FTLD. The most common mutation in GRN is Arg493X. We aimed to establish the contribution of this mutation to FTLD and related disorders.
  
  
  METHODS
  We measured the frequency of Arg493X in 3405 unrelated patients with various neurodegenerative diseases using Taqman single-nucleotide polymorphism (SNP) genotyping. Clinicopathological characterisation and shared haplotype analysis were done for 30 families with FTLD who carry Arg493X. To investigate the effect of potential modifying loci, we did linear regression analyses with onset age as the covariate for GRN variants, for genotypes of the apolipoprotein E gene (APOE), and for haplotypes of the microtubule-associated protein tau gene (MAPT).
  
  
  RESULTS
  Of 731 patients with FTLD, 16 (2%) carried Arg493X. This mutation was not detected in 2674 patients who did not have FTLD. In 37 patients with Arg493X from 30 families with FTLD, clinical diagnoses included frontotemporal dementia, primary progressive aphasia, corticobasal syndrome, and Alzheimer's disease. Range of onset age was 44-69 years. In all patients who came to autopsy (n=13), the pathological diagnosis was FTLD with neuronal inclusions that contained TAR DNA-binding protein or ubiquitin, but not tau. Neurofibrillary tangle pathology in the form of Braak staging correlated with overall neuropathology in the Arg493X carriers. Haplotype analyses suggested that Arg493X arose twice, with a single founder for 27 families. Linear regression analyses suggested that patients with SNP rs9897528 on their wild-type GRN allele have delayed symptom onset. Onset ages were not associated with the MAPT H1 or H2 haplotypes or APOE genotypes, but early memory deficits were associated with the presence of an APOE epsilon4 allele.
  
  
  CONCLUSIONS
  Clinical heterogeneity is associated with GRN haploinsufficiency, and genetic variability on the wild-type GRN allele might have a role in the age-related disease penetrance of GRN mutations.
authors.affiliation: Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA. rademakers.rosa@mayo.edu
authors.forename: Rosa
authors.initials: R
authors.lastname: Rademakers
authors.forename: Matt
authors.initials: M
authors.lastname: Baker
authors.forename: Jennifer
authors.initials: J
authors.lastname: Gass
authors.forename: Jennifer
authors.initials: J
authors.lastname: Adamson
authors.forename: Edward D
authors.initials: ED
authors.lastname: Huey
authors.forename: Parastoo
authors.initials: P
authors.lastname: Momeni
authors.forename: Salvatore
authors.initials: S
authors.lastname: Spina
authors.forename: Giovanni
authors.initials: G
authors.lastname: Coppola
authors.forename: Anna M
authors.initials: AM
authors.lastname: Karydas
authors.forename: Heather
authors.initials: H
authors.lastname: Stewart
authors.forename: Nancy
authors.initials: N
authors.lastname: Johnson
authors.forename: Ging-Yuek
authors.initials: GY
authors.lastname: Hsiung
authors.forename: Brendan
authors.initials: B
authors.lastname: Kelley
authors.forename: Karen
authors.initials: K
authors.lastname: Kuntz
authors.forename: Ellen
authors.initials: E
authors.lastname: Steinbart
authors.forename: Elisabeth McCarty
authors.initials: EM
authors.lastname: Wood
authors.forename: Chang-En
authors.initials: CE
authors.lastname: Yu
authors.forename: Keith
authors.initials: K
authors.lastname: Josephs
authors.forename: Eric
authors.initials: E
authors.lastname: Sorenson
authors.forename: Kyle B
authors.initials: KB
authors.lastname: Womack
authors.forename: Sandra
authors.initials: S
authors.lastname: Weintraub
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Pickering-Brown
authors.forename: Peter R
authors.initials: PR
authors.lastname: Schofield
authors.forename: William S
authors.initials: WS
authors.lastname: Brooks
authors.forename: Vivianna M
authors.initials: VM
authors.lastname: Van Deerlin
authors.forename: Julie
authors.initials: J
authors.lastname: Snowden
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Clark
authors.forename: Andrew
authors.initials: A
authors.lastname: Kertesz
authors.forename: Kevin
authors.initials: K
authors.lastname: Boylan
authors.forename: Bernardino
authors.initials: B
authors.lastname: Ghetti
authors.forename: David
authors.initials: D
authors.lastname: Neary
authors.forename: Gerard D
authors.initials: GD
authors.lastname: Schellenberg
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Beach
authors.forename: Marsel
authors.initials: M
authors.lastname: Mesulam
authors.forename: David
authors.initials: D
authors.lastname: Mann
authors.forename: Jordan
authors.initials: J
authors.lastname: Grafman
authors.forename: Ian R
authors.initials: IR
authors.lastname: Mackenzie
authors.forename: Howard
authors.initials: H
authors.lastname: Feldman
authors.forename: Thomas
authors.initials: T
authors.lastname: Bird
authors.forename: Ron
authors.initials: R
authors.lastname: Petersen
authors.forename: David
authors.initials: D
authors.lastname: Knopman
authors.forename: Bradley
authors.initials: B
authors.lastname: Boeve
authors.forename: Dan H
authors.initials: DH
authors.lastname: Geschwind
authors.forename: Bruce
authors.initials: B
authors.lastname: Miller
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Wszolek
authors.forename: Carol
authors.initials: C
authors.lastname: Lippa
authors.forename: Eileen H
authors.initials: EH
authors.lastname: Bigio
authors.forename: Dennis
authors.initials: D
authors.lastname: Dickson
authors.forename: Neill
authors.initials: N
authors.lastname: Graff-Radford
authors.forename: Mike
authors.initials: M
authors.lastname: Hutton
mesh_terms: D017668:Age of Onset; D000368:Aged; D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics; D018888:Aphasia, Primary Progressive / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics; D015331:Cohort Studies; D004268:DNA-Binding Proteins / Q000378:metabolism; D003704:Dementia / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D005260:Female; D018703:Founder Effect; D005838:Genotype; D006239:Haplotypes; D006579:Heterozygote; D006801:Humans; D002479:Inclusion Bodies / Q000473:pathology; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics*; D008297:Male; D008569:Memory Disorders / Q000453:epidemiology / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D019636:Neurodegenerative Diseases / Q000453:epidemiology / Q000235:genetics*; D016874:Neurofibrillary Tangles / Q000473:pathology; D009474:Neurons / Q000473:pathology; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D000077153:Progranulins; D012189:Retrospective Studies; D025801:Ubiquitin / Q000378:metabolism; D016875:tau Proteins / Q000235:genetics